,i  #aai? ,,congress  #b;d ,session  ,h4
 ,r4 #hadc  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,m>* #bg1 #bjbf ,ms4  
,matsui 7= h]self1 ,mrs4 ,mill]-,meeks1 
& ,mr4 ,au*9closs7 introduc$ ! foll[+   
bill2 :i* 0 ref]r$ to ! ,committee on   
,en]gy & ,comm]ce1 & 9 addition to !    
,committee on ,ways & ,means1 = a p]iod 
to be subsequ5tly det]m9$ by ! ,speak]1 
9 ea* case = consid]ation ( su*         
provisions z fall )9 ! jurisdiction ( ! 
committee conc]n$  ,a ,,bill  ,to am5d  
title ,,xviii ( ! ,social ,security ,act
 to require ,,pdp sponsors ( a          
prescription drug plan "u "p ,d ( !     
,m$ic>e program t use a =mul>y to       
include c]ta9 g5]ic drugs & biosimil>   
biological products on su* =mul>y1 & =  
o!r purposes4  #a4 ,%ort title ,?is ,act
 may be cit$ z ! ,ensur+ ,access to     
,l[]-,co/ ,m$ic9es = ,s5iors ,act (     
#bjbf4  #b4 ,requirem5ts = pdp sponsors 
( prescription drug plans "u "p d ( !   
m$ic>e program t use =mul>ies ,section  
#ahfj;,d-#d7;b77#c7 ( ! ,social         

,security ,act 7#db ,u4,s4,c4           
#aciew-#ajd7;b77#c77 is am5d$ by add+ at
 ! end ! foll[+ new subp>agraph3  7,j7  
,requir$ inclusion ( c]ta9 g5]ic drugs &
 biosimil> biological products  7i7  ,9 
g5]al  ,) respect to a plan ye> beg9n+  
on or aft] ,janu>y #a1 #bjbg1 ! =mul>y  
%all include 9 a pref]r$ position       
relative to ! ref]5ce drug--  7,i7 ea*  
cov]$ g5]ic drug = :i* ! :olesale       
acquisition co/ is less ?an ! :olesale  
acquisition co/ ( ! ref]5ce drug ( su*  
cov]$ g5]ic drug2 &  7,,ii7 at lea/ two 
cov]$ bio-simil> biological products =  
:i* ! :olesale acquisition co/ is less  
?an ! :olesale acquisition co/ ( !      
ref]5ce biological product ( su* cov]$  
biosimil> biological product4  7ii7     
,prohibition on c]ta9 lim-its on access 
,! ,,pdp sponsor (f]+ ! prescription    
drug plan may n impose limits on access 
to a cov]$ g5]ic drug requir$ to be     
includ$ on ! =mul>y "u clause 7i77,i7 or
 a cov]$ biosimil> biological product   
requir$ to be includ$ on ! =mul>y "u    

clause 7i77,,ii71 includ+ ?r\gh         
utilization managem5t te*niques su* z   
prior au?orization1 or /ep !rapy1 t are 
m re/rictive ?an any su* limits impos$  
on access to ! ref]5ce drug ( su* cov]$ 
g5]ic drug or ref]5ce biological product
 ( su* cov]$ biosimil> biological       
product1 respectively1 or t o!rwise h ! 
effect ( limit+ ! availability to       
enrollees ( su* cov]$ g5]ic drug or     
cov]$ biosimil> biological product      
relative to su* ref]5ce drug or ref]5ce 
biological product ov] su* cov]$ g5]ic  
drug or cov]$ biosimil> biological      
product1 respectively4  7iii7           
,def9itions  ,9 ?is subp>agraph &       
subp>agraph 7,j73 7,i7 ,cov]$ biosimil> 
biological product ,! t]m cov]$         
biosimil> biological product means a    
cov]$ "p ,d drug t is a biosimil>       
biological product 7z def9$ 9 section   
#ahdg;,a7c77#f77;,h774  7,,ii7  ,cov]$  
g5]ic drug  ,! t]m cov]$ g5]ic drug     
means a cov]$ "p ,d drug t is a drug    
describ$ 9 section                      

#ahfj;,d-#b7;e77#a77;,a7 & approv$ "u   
section #eje7;j7 ( ! ,f$]al ,food1      
,drug1 & ,cosmetic ,act4  7,,iii7       
,pref]r$ position  ,! t]m pref]r$       
position means a product is plac$ on a m
 favorable =mul>y ti] & has l[] pati5t  
out-(-pocket co/s ?an ! correspond+     
ref]5ce drug or ref]5ce biological      
product4  7,,iv7  ,ref]5ce biological   
product  ,! t]m ref]5ce biological      
product has ! mean+ giv5 su* t]m 9      
section #ahdg;,a7c77#f77;,i74  7,v7     
,ref]5ce drug  ,! t]m ref]5ce drug      
means1 ) respect to a cov]$ g5]ic drug1 
! li/$ drug 7z describ$ 9 clause 7i7 (  
section #eje7;j77#b77;,a7 ( ! ,f$]al    
,food1 ,drug1 & ,cosmetic ,act7 t is    
ref]r$ to 9 ! abbreviat$ application =  
su* cov]$ g5]ic drug "u su* section4    
7,,vi7  ,:olesale acquisition co/  ,!   
t]m :olesale acquisition co/ has ! mean+
 giv5 su* t]m 9 section                 
#ahdg;,a7c77#f77;,b74  4